Antimicrobial Activity of Lysozyme against Oral Pathogens

T. Jesse Joel, S. Suguna, S. R. Steff


Saliva contains a number of antimicrobial substances which have their origin either in salivary glands or serum from which they may leak into the mouth via the gingival crevices. Saliva is believed to possess a substantial influence on the aggregates oral pathogens form in the mouth due to the antibodies as well as proteins whose antimicrobial properties do not depend on prior exposure to an antigen. One such enzyme is Lysozyme which is one of the most powerful natural antibacterial and antiviral compounds known to man. According to previous researches, it has been found out that lysozyme may bind and aggregate Gram-positive bacteria such as putative Gram-negative periodontopathic bacteria such as Capnocytophaga gingivalis. This particular study explores the natural phenomenon Lysozyme exhibits against oral microflora with noteworthy conclusions. Saliva samples were collected from the oral cavity of human, cow and dog. From these samples, lysozyme was isolated and purified. Furthermore, the quantity of the enzyme isolated was ascertained by Polyacrylamide Gel Electrophoresis. The quantified enzyme showed 32kDa for cow sample, 23kDa for dog sample and 23kDa for human sample. Finally the antimicrobial activity of the enzyme was determined by agar well diffusion method against Staphylococcus spp. and Enterococcus faecalis. Hence lysozyme in saliva is found to have the antibacterial activity against the pathogen due to the zone of inhibition observed and this proves that a tool to prevent dental decay is available and that there is potential to serve antimicrobial role in the specific application of medical industry.

Full Text:



Tenovo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme, and lactoferrin in xerostomia: efficacy and safety. Orl Dis. 2002; 8(1):23–9.

Gibbons RJ, Hay DI. Human Salivary Acidic Proline-Rich Proteins and Statherin Promote the attachment of Actinomyces viscosus LY7 to Apatitic Surfaces. Infect Immun. 1988; 56:439–45.

Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun. 1985 Jun; 48(3):720–8.

Wang YB, Germaine GR. Effect of lysozyme on glucose fermentation, cytoplasmic pH, and intracellular potassium concentrations in Streptococcus mutans 10449. Infect Immun. 1991; 59(2):638–44.

Jenzano JW, Hogan SL, Lundblad RL. Factors Influencing Measurement of Human Salivary Lysozyme in Lysoplate and Turbidimetric Assays. J Clin Microbial. 1986; 24(6):963–7.

Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43:12.

Fujita A, Shimizu I, Abe T. Distribution of lysozyme and protease, and amino acid concentration in the guts of a wood-feeding termite. Reticulitermes spates (Kolbe): Possible digestion of symbiont bacteria transferred by trophallaxis. Physiological Entomology. 2001; 26:116–23.

Hultmark D. Insect lysozyme. In: Jolles P, editor. Lysozymes: Model Enzymes in Biochemistry and Biology. Birkhauser Vela Basel, Switzerland. 1996; 87–102.

Moto T. Engineering of lysozyme. In: Jolles P, editor. Lysozymes: Model Enzymes in Biochemistry and Biology. Birkhauser Vela, Basel, Switzerland. 1996; 163–81.

Jelles P, Jolles J. What’s new in lysozyme research? Always a model system, today as yesterday. Molecular and Cellular Biochemistry. 1984; 63:165–89.

Kang D, Romans P, Lee JY. Analysis of a lysozyme gene from the malaria vector mosquito Anopheles gambiae. Gene. 1996; 174:239–44.

Barrett AJ. The Cystatins: A New Class of Peptidase Inhibitors. Trends Biochem Sci. 1987; 12:193–6.


  • There are currently no refbacks.


 Creative Commons 

Listed as Green Publisher